Medsafe, New Zealand's regulator of medicines and medical devices, has given approval for psychiatrists to pre...
Japanese pharmaceutical company Shionogi & Co. has entered into an exclusive licensing agreement with Link Medical P...
Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has an...
The Prime Minister of New Zealand, Christopher Luxon, recently chaired an education focused event at the Indian Institut...
US-based startup Tetrous, Inc., focused on bone-to-tendon healing following orthopedic surgery, has announced the s...
Health Ministry in New Zealand has launched a Strategic Approach to Immunisation 2025–2030, to provide a renewed v...
A signing ceremony with New Zealand Prime Minister Christopher Luxon and Franco-Vietnamese (FV) Hospital ...
Minister Shane Reti, whose portfolios include Science Innovation and Technology, and Universities, chose the Auckla...
Smith+Nephew, the global medical technology company, has announced the launch of a comprehensive foot & ankle repair...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been releas...
New Zealand-based University of Auckland-led project plans to develop a tool to predict the risk and mitigate the effect...
More than $4.3 million from the Health Research Council in New Zealand will allow University of Auckland researchers to ...
Aidoc, a global pioneer in clinical artificial intelligence (AI) solutions, has announced the expansion of its partnersh...
The Health Ministry in New Zealand has announced that a new Mental Health Bill has been introduced and is now publicly a...
A plan aiming to streamline clinical trial reporting procedures in some circumstances is now out for consultation in New...
Invasive group A streptococcal infection (iGAS) will become a “notifiable” disease on 1 October 2024, enhanc...
The Ministry of Health has published New Zealand’s first dedicated, health system-led strategy for people with rar...
FebriDx, Lumos' rapid point-of-care test, is now available to healthcare practitioners in Australia and New Zealand, fol...
